Vergelijking

Goserelin vs. Pasireotid

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

65807-02-5

396091-73-9

Molecuulmassa

1269.43 g/mol

1047.21 g/mol

Halfwaardetijd

4.2 h

geen gegevens

Sequentie

pGlu-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azgly-NH2

geen gegevens

Werkingsmechanisme

Goserelin

As a GnRH agonist, goserelin binds to the GnRH receptors of the pituitary gland. Initial stimulation transiently raises luteinizing hormone (LH) and follicle-stimulating hormone (FSH). With continuous receptor occupancy, however, the receptors become desensitized and down-regulated, which reduces LH and FSH secretion and consequently the production of testosterone or estrogen. This mechanistic relationship is documented in the pharmacological literature.

Pasireotid

Pasireotide binds more broadly than older somatostatin analogs (SSTR1/2/3/5) with particularly high affinity for SSTR5. This suppresses, among others, ACTH release in Cushing's disease and GH release in acromegaly.

Bewijsbasis

Hoogste bewijs

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Goserelin	Pasireotid
Duitsland	Op recept	Op recept
Verenigde Staten	Op recept	Op recept

Volledige vermeldingen

Goserelin

Volledige vermelding →

Pasireotid

Volledige vermelding →

Frequently asked questions

What is the difference between Goserelin and Pasireotid?: Goserelin is classified as "Onderzoek (overig)", while Pasireotid is classified as "Onderzoek (overig)". Goserelin: Goserelin is a synthetic decapeptide and an agonist of gonadotropin-releasing hormone (GnRH). The medical literature describes it as a hormonal agent that suppresses the release of sex hormones through sustained receptor stimulation. Regulatory-approved indications include prostate cancer, advanced breast cancer, endometriosis, and endometrial thinning, among others. Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Goserelin or Pasireotid?: The highest available evidence level is "Humane RCT" for Goserelin and "Humane RCT" for Pasireotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Goserelin and Pasireotid in Germany and the United States?: Duitsland: Goserelin — Op recept, Pasireotid — Op recept. Verenigde Staten: Goserelin — Op recept, Pasireotid — Op recept. These are factual summaries with source and review date on the individual pages.

Country

Goserelin

Pasireotid

Duitsland

Op recept

Verenigde Staten

Op recept

Frequently asked questions

What is the difference between Goserelin and Pasireotid?

Goserelin is classified as "Onderzoek (overig)", while Pasireotid is classified as "Onderzoek (overig)". Goserelin: Goserelin is a synthetic decapeptide and an agonist of gonadotropin-releasing hormone (GnRH). The medical literature describes it as a hormonal agent that suppresses the release of sex hormones through sustained receptor stimulation. Regulatory-approved indications include prostate cancer, advanced breast cancer, endometriosis, and endometrial thinning, among others. Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Goserelin or Pasireotid?

The highest available evidence level is "Humane RCT" for Goserelin and "Humane RCT" for Pasireotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Goserelin and Pasireotid in Germany and the United States?

Duitsland: Goserelin — Op recept, Pasireotid — Op recept. Verenigde Staten: Goserelin — Op recept, Pasireotid — Op recept. These are factual summaries with source and review date on the individual pages.